Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126718
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-13
First Post:
2023-11-02
Brief Title:
Phase I Randomized Open-label Parallel-controlled Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
Sponsor:
BioRay Pharmaceutical Co Ltd
Organization:
BioRay Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Psoriasis |
Keywords: